Psilocybin for Opioid Use Disorder in Patients on Methadone Maintenance With Ongoing Opioid Use
Status:
Not yet recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
This study will investigate whether psilocybin administered under supportive conditions can
reduce illicit opioid use and improve quality of life in individuals with Opioid Use Disorder
(OUD) in Methadone Maintenance Treatment (MMT) who are concurrently using other opioids
illicitly.